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NOMENCLATURE 
 
ADP  Adenosine di-phosphate 
ATP  Adenosine tri-phosphate 
Asc  Ascorbate 
bc1 Ubiquinol-cytochrome c oxidoreductase 
bH Higher potential cytochrome b heme 
bL Lower potential cytochrome b heme 
Cyt  Cytochrome 
CO  Carbon monoxide 
DNA  Deoxyribonucleic Acid 
DSC  Differential scanning calorimetry 
E. coli  Escherichia coli 
EDTA  Ethylenediaminetetramethylacetic acid 
Em  Midpoint potential 
FAD  Flavin adenosine dinucleotide – oxidized form 
FADH2 Flavin adenosine dinucleotide – reduced form 
HRP  horseradish peroxidase 
ICM  Intracytoplasmic membrane 
ISP  Iron Sulfur Protein 
KDa  Kilo Daltons 
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Kb  Kilo Base-pairs 
LB  Luria Broth 
ME  Mercaptoethanol 
NAD  Nicotinamide adenosine dinucleotide – oxidized form 
NADH2 Nicotinamide adenosine dinucleotide – reduced form 
PAGE  Polyacrylamide gel electrophoresis 
Pi  Inroganic phosphate 




Qi  Inside ubiquinol site 
Qo  Outside ubiquinone site 
Q0C10BrH2 2,3-Dimethoxy-5-methyl-6-(10-bromodecyl)-1,4-benzoquinol 
Rb.   Rhodobacter 
SDS  Sodium dodecyl sulfate 
Tm  Melting temperature 
TMBZ  3,3’,5,5’-tetramethyl benzidine dihydrochloride 
UV  Ultra Violet  







A. Mitochondrial respiratory chain  
 
In eukaryotes, mitochondria perform several fundamental cellular functions. 
The major function of mitochondria is to generate energy for cellular activity through 
oxidative phosphorylation (Fig. 1), which is based on the sequential operation of five 
protein complexes, complexes I through V, four of which constitute the mitochondrial 
electron transfer chain; complexes I through IV. NADH and succinate, two products 
of the citric acid cycle, are electron donors of the electron transfer chain through 
complex I and complex II, respectively. Complex I, NADH-ubiquinone 
oxidoreductase, transfers electrons from NADH to ubiquinone. Complex II, 
succinate-ubiquinone oxidoreductase, transfers electrons from succinate to 
ubiquinone. Ubiquinol reduces complex III, ubiquinol-cytochrome c reductase, which 
transfers the electron through cytochrome c to complex IV, cytochrome c oxidase. 
The final electron acceptor in the electron transfer chain is oxygen. Electron transfer 
through these complexes, except for complex II, is coupled to proton translocation 
from the matrix into the inter-membrane space, establishing a proton gradient across 
the inner membrane. Complex V, ATP synthase, uses this transmembrane proton 
gradient to drive the endergonic reaction of ATP synthesis. The conversion of 
osmotic energy of the gradient into chemical energy, achieved by complex V, is 
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Figure 1: Mitochondrial electron transport chain complexes. Black arrows and 




known as the chemiosmotic coupling process. 
In the aerobic respiratory system of bacteria, complex III, also referred to as 
the cytochrome bc1 complex, perform a similar function as in the mitochondria. In 
chloroplasts and cyanobacteria, the bc1 complex is substituted by a similar complex 
called the cytochrome b6f or plastoquinol-plastocyanin oxidoreductase that performs 
the same function in the electron transfer chain. Similarity between the two 
complexes is high enough to believe most features discussed about one complex 
apply to the other. 
 
B. The cytochrome bc1 complex  
The cytochrome bc1 complex is a vital constituent of the electron transfer 
pathway of mitochondria and many respiratory and photosynthetic bacteria (1-5). It 
catalyzes the electron transfer from quinol to a c-type cytochrome with generation of 
a proton gradient used for ATP synthesis. All cytochrome bc1 complexes contain 
three redox subunits (Table 1) housing four redox centers: cytochrome b, which 
houses two b-type hemes (bL or b566 and bH or b562), cytochrome c1 which houses a c-
type heme and the Rieske iron-sulfur protein, which houses a high-potential [2Fe2S] 
cluster (4). Some cytochrome bc1 complexes consist of additional supernumerary 
subunits that vary in number in different species (Table 1). For example, the bc1
complex in bovine heart contains eight supernumerary subunits (6), in yeast, it 
contains seven (7), in Rhodobacter sphaeroides it has only one (8) and none in 
Rhodobacter capsulatus (9). Although the function of supernumerary subunits is still 
not fully understood, it is well established that complexes lacking these subunits are  
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(A) 
Core Subunits Prosthetic Group 
Cytochrome b Hemes bL and bH
Cytochrome c1 Heme c1
Rieske Iron Sulfur Protein [2Fe2S] Iron Sulfur Cluster 
(B) 
Source Core Subunit Supernumerary Subunit 
Bovine 3 8 
Yeast 3 7 
Rhodobacter sphaeroides 3 1
Rhodobacter capsulatus 3 0
Paracoccus denitrificans 3 0
Table 1: (A) The three prosthetic groups found in all cytochrome bc1 complex.  
(B) Number of core subunits and supernumerary subunits found in the 
cytochrome bc1 complex from different species. 
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less stable and show lower enzyme activity compared to complexes with 
supernumerary subunits (7,10). Therefore, it is possible that increased stability and 
activity of the complex result from the interaction between the redox subunits and the 
supernumerary subunits.  
 
C. The Q cycle mechanism 
The “protonmotive Q Cycle” hypothesis, proposed by Peter Mitchell (11), 
explains electron transfer and proton translocation in the cytochrome bc1 complex. Up 
to this date, several different opinions were projected about the mechanism through 
which the bc1 complex operates but the “Q Cycle mechanism” is the generally 
accepted one because it fully explains the kinetics of reduction of cytochrome c1 and 
heme bH (12).  
The two major features of the Q cycle mechanism (Fig. 2) are, first, the existence of 
two ubiquinone binding site (Qo and Qi sites) and second, the bifurcated reaction at 
the Qo site (13). In the first turnover of the cycle, one ubiquinol molecule (QH2) is 
oxidized at the Qo site on the positive side of the inner mitochondrial membrane 
where the two electrons diverge with one electron transferred to the high potential 
chain through 2Fe2S cluster (Em= 280mV) then heme c1 (Em=227mV) to cytochrome 
c and the second electron transferred to the low potential chain through heme bL (Em =
-30mV) to heme bH (Em = 90mV) which reduces ubiquinone (Q) to ubisemiquinone 
(QH.) at the Qi site uptaking one proton from the matrix. In the second turnover of the 
cycle, the bifurcated electrons at the Qo site follow the same two paths except that 
heme bH will transfer the electron to ubisemiquinone, generated in the first turnover,  
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Figure 2: The Q-cycle mechanism showing the reactions catalyzed by the bc1
complex. The first turnover of the cycle follows the arrow labeled “1” 
reducing ubiquinone (Q) to ubisemiquinone (QH.-) and the second 
turnover of the cycle follows the arrow labeled “2” reducing 
ubisemiquinone  (QH.-) to ubiquinol (QH2). 
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and reduce it to ubiquinol (QH2), with the uptake of another proton from the matrix. 
Therefore, in a complete turnover of the cytochrome bc1 complex, as pointed out in 
the equation below, one quinone molecule is generated, two cytochrome c molecules 
are reduced and four protons are deposited in the intermembrane space; two protons 
are deposited upon oxidation of one QH2 molecule at the Qo site.   
QH2 + 2 cyt c3+ + 2H+ (in) => Q +  2 cyt c2+  + 4H+ (out) 
 
D. The three dimensional structure of the cytochrome bc1 complex 
The three-dimensional structure of the cytochrome bc1 complex from bovine 
heart mitochondria, chicken and yeast were determined by X-ray crystallography at a 
resolution of 2.4 Å (14) , 3.16 Å (15) and 2.3 Å (16), respectively . The bovine 
structure (Fig. 3) is the most complex one composed of three redox subunits and 
eleven supernumerary subunits, which fold into a pear-shaped dimeric structure of 
130 Å width and 155 Å height. The complex lengthens 38 Å in the intermembrane 
space from the inner membrane surface housing cytochrome c1 head and ISP head as 
well as subunit VIII. The complex extends 42 Å through the inner membrane 
consisting of five transmembrane helices from cytochrome b and one helix from each 
of cytochrome c1, ISP, subunits VII, X and XI. In the matrix region, the complex 
extends 75 Å and consists of CoreI and CoreII subunits, subunits VI and IX as well 
the C-terminal fragment of ISP and the N-terminal fragment of subunit VII (17). The 
structural features of the bc1 complex help understand the mechanism of function of 
the complex. So far, all structural data support the Q-cycle mechanism, the existence 
of the bc1 complex in an intertwined dimeric conformation and the essentiality of the  
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Figure 3. The intertwined dimeric structure of bovine cytochrome bc1 complex 
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head domain movement of ISP for bc1 catalysis. 
 
1. The intertwined dimeric structure of the bc1 complex
Crystallographic observations suggest that the bc1 complex exists and 
functions as a dimer with the ISPs of the two monomers intertwined as the ISP tail 
folds in one monomer and its head domain is in close proximity with cyt b and cyt c1
of the other monomer. To further confirm this observation, mutant bc1 complexes 
were generated where two disulfide bonds were introduced between ISP and cyt b,
one between the head domain of ISP and cyt b and the other one between the tail 
domain of ISP and cyt b. SDS-PAGE analysis of this mutant, which shows an adduct 
protein of molecular weight 128KDa consisting of two cyt b subunits and two ISP 
subunits, confirm that the bc1 complex exists as a dimer with intertwining ISPs (18).  
 The functional significance of the dimeric structure of the complex was also 
implied by studying electron transfer between the two heme bLs of the bc1 complex. 
The distance between the two heme bLs is short enough (21 Å) to allow this transfer 
and  recent studies revealed that disruption of electron transfer between the two bL
hemes increases electron leakage to oxygen resulting in decreased ubiquinol-
cytochrome c reductase activity (19). 
 
2. Head domain movement of ISP
As revealed by the structure, ISP tail domain (N-terminal) spans the inner 
membrane and its neck and head domain (C-terminal) are located in the 
intermembrane space. The head domain movement of ISP between Qo site and cyt c1
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of about 22 Å is presumed critical in the bifurcation of the electron pathway (15). The 
head domain movement of ISP was further supported by the observation of different 
[2Fe-2S] cluster positions using different types of Qo inhibitors which either fix ISP 
head domain in cyt b position or leave ISP head domain mobile (20-22). Moreover, 
several studies were done on a molecular level confirming the crucial role of the head 
movement in bc1 catalysis. By increasing the rigidity of the neck domain of ISP by 
amino acid substitution to Proline (23) or by introducing a disulfide bond in the neck 
region (24), which decreases the flexibility of the head domain, the enzymatic activity 
of the bc1 complex was decreased. In the latter case, activity can be restored only by 
reducing the disulfide bond. Moreover, a disulfide bond was introduced between the 
head domain of ISP and cytochrome b to completely immobilize the head domain in 
the b-position. Formation of the inter-subunit disulfide bond completely abolishes the 
cytochrome bc1 activity which can be restored to normal activity by reducing the 
disulfide bond with β-mercaptoethanol (25).  
The ISP head domain movement hypothesis may also explain the bifurcated 
reaction at the Qo site. When quinol is oxidized at the Qo site, one electron is passed 
to the high potential chain through [2Fe-2S] cluster and the second electron is passed 
to the low potential chain through heme bL. The latter thermodynamically 
unfavorable process could be explained by the head domain movement of ISP; in one 
model, when the first electron is passed to the iron-sulfur cluster of ISP, ISP head is 
held in the b-position. The iron sulfur cluster being reduced, it cannot accept another 
electron and only after the second electron is passed to the low potential chain, ISP 
head moves toward cyt c1 (26-27). In a different model, proposed by Xiao et. al. (18), 
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ISP head is held in the c1-position, too far from the Qo site for the second electron to 
be transferred to it, until the second electron is passed to heme bL.
All features of bovine bc1 complex discussed above also apply to the 
Rhodobacter sphaeroides bc1 complex, which was used as the study system in this 
thesis.  
 
E. Photosynthetic bacterium Rhodobacter sphaeroides cytochrome bc1 complex 
The photosynthetic bacterium Rb. sphaeroides is an anoxygenic purple 
bacterium that carries out photosynthesis under anaerobic conditions without 
producing oxygen, in contrast to plants and algae. Rb. sphaeroides can also grow 
under aerobic conditions in the dark when cytochrome bc1 complex is dispensable for 
the bacterium growth. Therefore, mutated bc1 complex that cannot support 
photosynthetic cell growth can still be purified. In photosynthetic growth under 
anaerobic conditions, the cyt bc1 complex is required for bacterial growth to transfer 
electrons from quinol to cytochrome c2. If the cyt bc1 complex is defective and cannot 
support photosynthetic growth, cells can be grown under semi-aerobic conditions in 
the dark where the cyt bc1 complex is not required because of the presence of quinol 
oxidase, which transfers the electron directly to oxygen in a cyt bc1-independent 
pathway. Under these conditions, intracytoplasmic membrane (ICM) is synthesized 
from which defective cyt bc1 complex can be purified and characterized. The ability 
of Rb. sphaeroides to grow under semi-aerobic and anerobic conditions, synthesizing 
cyt bc1 complex under either condition, makes it an ideal system for the study of the 
cyt bc1 complex. Besides, the bacterial cyt bc1 complex is a simple protein composed 
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of only four subunits, three catalytic subunits (cyto b, cyt c1 and ISP) similar to their 
bovine counterparts and one supernumerary subunit, subunit IV. All subunits are 
encoded by genes organized in an fbcFBCQ operon, which was deleted from the 
chromosome of Rb. sphaeroides to facilitate mutagenesis studies. Each of cyt b, cyt 
c1, ISP and subunit IV of the cyt bc1 complex can be characterized individually using 
molecular and biochemical techniques to further visualize the structure of the subunit 
and understand its function in cyt bc1 complex catalytic activity. This study focuses 
on cyt c1 subunit of Rb. sphaeroides cyt bc1 complex. Several mutagenic and 
biochemical techniques are used to depict new structural and functional features of 
Rb. sphaeroides cyt c1 that cannot be envisioned in the bovine structure of the bc1
complex. 
 
F. Cytochrome c1 subunit 
Mitochondrial cytochrome c1 was discovered in 1940 by two independent 
groups, Yakushiji & Okunaki (28) and Keilin & Hartree (29) and its sequence was 
determined in 1980 by Wakabayashi et. al. (30). It consists of 241 residues and is 
synthesized as a precursor with a leading sequence of around 80 residues (31). 
Cytochrome c1 folds in a similar way to cytochrome c and other class I cytochromes 
with some insertions and deletions in different linker peptides between the core 
helices. Cytochrome c1 assembles into an extrinsic hydrophilic domain anchored to 
the membrane through a C-terminal hydrophobic transmembrane α-helice.   
Rhodobacter sphaeroides cytochrome c1 is composed of 263 amino acids but 
is synthesized as a precursor with 285 amino acids (32) and has a theoretical 
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molecular mass of 30.5KDa but is identified as a protein with a molecular weight of 
34KDa on SDS-PAGE. In overloaded samples, cytochrome c1 can be identified on 
gels by the color of the covalently bound heme or by the peroxidase activity of the 
heme.  
Mature Rb. sphaeroides cytochrome c1 houses a type c heme and contains the 
conserved CXXCH heme-binding consensus sequence in the head domain, located 37 
residues downstream of the N-terminus that covalently binds the heme group through 
the two cysteins Cys37 and Cys40. The fifth axial ligand to the heme iron is His41 
and the sixth axial ligand is a conserved methionine located at residue 185, close to 
the C-terminus end. Sequence alignment between bovine and Rb. sphaeroides cyt c1
reveals two fragment insertions in the bacterial cyt c1; the first 17-amino acid 
fragment extends from residue Gly109 to Ile125 located downstream of the conserved 
PDL sequence and the second 19-amino acid fragment extends from residue Gln161 
to Ala179 located upstream of the sixth ligand to the heme, Met185. These insertions 
are absent in cytochromes c1 of higher organisms such as bovine and yeast but are 
present in Rb. capsulatus and Rb. sphaeroides. The second extra fragment includes a 
cystein at residue 169 that aligns with Cys167 of Rb. capsulatus. Another cystein 
residue is located at residue 145 in Rb. sphaeroides that aligns with Cys144 in Rb. 
capsulatus. Because the two cysteins are absent in cyt c1 sequence of higher 
organisms, such as bovine, chicken and yeast, whose crystal structure was solved (16, 
33-36), no structural data can assert the orientation and state of the cystein residues in 
native Rb. sphaeroides bc1 complex. 
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G. Purpose of study 
 Recently, Ozyczka, A et. al. (37) reported that the two cysteins in Rb. capsulatus 
cyt c1 form a disulfide bridge. When the bridge is disrupted, a second site suppression 
mutation of Ala181 to a β-branched amino acid (Thr or Val) spontaneously occur and 
the functionality of the cytochrome bc1 complex is restored. This mutation was found 
to be located two residues away (βXM) from the sixth axial ligand to the heme, 
Met183. The presence of either the disulfide bond or the βXM residue was found to 
be sufficient to maintain an active cytochrome bc1 complex. When cysteins were 
mutated to alanine and a β-branched amino acid was inserted at βXM position, the 
redox potential of Rb. capsulatus cyt c1 was lowered from 320mV to 227mV, which 
is comparable to that of wild type Rb. sphaeroides cyt c1. This would suggest that Rb. 
sphaeroides cyt c1 which has comparable properties, a β-branched amino acid (Ile) at 
position βXM and a redox potential of 230mV, does not have a disulfide bond. The 
presence of a disulfide bond in Rb. capsulatus cyt c1 was confirmed by the crystal 
structure data of the Rb. capsulatus cyt bc1 complex at 3.8Å (38). 
Herein, we investigate the state of the cysteins in Rb. sphaeroides cyt c1 using 
genetic and biochemical techniques. The photosynthetic growth behavior, cyt bc1
complex activity and stability and redox potential of cyt c1 in purified complex from 
wild type and mutant strains were determined and examined. Factor Xa catalysis was 
performed and analyzed by SDS-PAGE and Western blot. All results reveal that the 
two non-heme binding cysteins are connected through a disulfide bridge. We believe 
that when the bridge is disrupted, the second extra fragment loop (Gln161-Ala179) 
which includes one of the cysteins is released resulting in fluctuation of the loop. This 
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structural alteration results in a change in the functionality of cyt c1 and the stability 








Cytochrome c (from horse heart) and TMBZ (3, 3’, 5, 5’-tetramethyl benzidine 
dihydrochloride) were purchased from Sigma. N-Dodecyl-β-D-maltoside (LM) and 
N-octyl-β-D-glucoside (OG) were from Anatrace.  Ni-NTA gel and Qiaprep Spin 
Miniprep Kit were from Qiagen. 2, 3-Dimethoxy-5-methyl-6-(10-bromodecyl)-1, 4-
benzoquinol (Q0C10BrH2) was prepared in our lab as previously reported (39). Bovine 
Heart cyt c1 was purified according to the previously published method (40). 
 
B. Methods 
1. Growth of Bacteria: 
E. coli cells were grown at 37ºC in LB medium. Rhodobacter sphaeroides BC17 
cells bearing pRKDfbcFBC6HQ (41) plasmid containing the fbc genes were grown 
photosynthetically at 30ºC in an enriched Sistrom medium containing 5mM glutamate 
and 0.2% casamino acids. Photosynthetic growth conditions for Rb sphaeroides were 
essentially as described previously (42). Antibiotics were added to the following 
concentrations: 125µg/mL ampicillin, 40µg/mL Kanamycin sulfate, 10µg/mL 
tetracycline for E. coli and 1µg/mL for Rb. sphaeroides, 100µg/mL trimethoprim
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for E. coli and 30µg/mL for R. sphaeroides.
2. Generation of Rb. Sphaeroides expressing mutants of bc1 complex:
Mutations were constructed by site-directed mutagenesis using the QuickChange 
system from Stratagene. The double stranded pGEMC6HQ was used as template. 
pGEMC6HQ was constructed by ligating the XbaI-HindIII fragment of 
pRKDfbcFBC6HQ (41) into the XbaI-HindIII digested pGEM7Zf(+). The following 
primers were used to introduce single mutations in cyt c1
C145A primer:  
5’GGCTCATGGCCTTCGGCGGCTTTCGGCGGCTCTTCCG 3’ 
C169A primer:  
5’CGCCGTTCGCGTCCTTGGCGGTGTCGGGGACCG 3’ 
C145S primer:   
5’CGGTCCCCGACACCAGCAAGGACGCGAAC 3’ 
C169S primer: 5’GTTCGCGTCCTTGCTGGTGTCGGGGACCG 3’ 
 A template with double mutation C145S/C169S was constructed using 
pGEM/C6HQ with a single mutation at C145S as template and C169S primers. A 
similar method was used to construct C145A/C169A. 
 The following primer were used to introduce Factor Xa cleavage site  
P151I/F154R primer:  
5’GCCGAAGGCCATGAGATCGACGGCAGGTACTACAACCGCGCCTTC 3’ 
 The presence of mutations on cyt c1 was confirmed by DNA sequencing which 
was carried out at the Recombinant DNA/Protein Core Facility at Oklahoma State 
- 18 -
University. Plasmid bearing successful mutations on cyt c1 (C*) was digested with 
XbaI and HindIII and the C*6HQ bearing fragment was purified and ligated to the 
pRKDfbcFB vector, generated from digestion of pKDfbcFBC6HQ plasmid with XbaI 
and HindIII.  The generated pRKDfbcFBC*6HQ plasmid was chemically transformed 
to E. coli S17 cells. A plate mating procedure (41) was then used to mobilize the 
plasmid from E. coli S17 into Rb. sphaeroides BC17.  
 
3. Purification of cyt bc1 complex from Rb. sphaeroides
Chromatophore membranes were prepared as described previously (23) and 
stored at -80º C in the presence of 20% glycerol until use. Frozen chromatophores 
were used to prepare cyt bc1 complex and stored at – 80º C in the presence of 10% 
glycerol as decribed by Tian et al (23)  
 Protein concentration was determined based on absorbance at 280nm using a 
converting factor of 1 O.D280 = 0.56 mg/mL.cm. Cyt b (43) and cyt c1 (44) 
concentrations were determined spectrophotometrically as published previously. 
 
4. Activity assay of purified bc1 complex
To assay the activity of cyt bc1 complex in chromatophore membrane or 
intracytoplasmic membrane or in purified protein, the preparations were diluted to a 
final cytochrome b concentration of 3 µM with 50mM Tris-Cl, pH 8.0, containing 
200mM NaCl and 0.01%LM. Aliqouts of 2, 4 or 6 µL of the diluted sample was 
added to 1 mL of assay mixture containing 0.3mM EDTA, and 100 µM cyt c in 
100mM Na+/K+ phosphate buffer, pH 7.4.  The assays were started by addition of 25 
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µM Q2H2. Activity was determined by measuring the reduction of cyt c, which is 
monitored by the increase in absorbance at 550 nm in a Shimadzu UV 2102 PC 
spectrophotometer at 23ºC, using a millimolar extinction coefficient of 18.5. For 
calculation purposes, the non-enzymatic oxidation of Q2H2 in the absence of enzyme 
under these conditions was subtracted.  
 
5. Gel electrophoresis and Western Blot preparation and TMBZ heme staining
Sodium dodecyl sulfate - polyacrylamide gel electrophoresis (SDS-PAGE) was 
performed according to Laemmle (45) using Bio-Rad Mini Protean dual slab vertical 
cell. Samples were digested with 10mM Tris-Cl buffer, pH 6.8 containing 1% SDS 
and 3% glycerol in the presence or absence of 0.4% β-mercaptoethanol for 15 min at 
23ºC or 5 min at 60ºC before being subjected to electrophoresis.  
 Western blot was performed with rabbit monoclonal antibodies against cyt c1 or 
against His-tag. The polypeptides separated by SDS-PAGE were transferred to a 
polyvinylidene difluoride membrane for immunoblotting. Goat anti-rabbit IgG 
conjugated to alkaline phosphatase or protein A conjugated to horseradish peroxidase 
(HRP) was used as second antibody. Color development was done using HRP color 
development solution. 
 For TMBZ heme staining, 35mL of 0.25M sodium acetate (pH 5.0) were mixed 
with 15mL of freshly prepared solution of 6.3mM TMBZ and added to the blotted 
membrane. The membrane was incubated shaking for 45min followed by the addition 
of 1.1mL 30% hydrogen peroxide. Color development was observed within 5-15min.  
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6. Carbon monoxide binding experiment
Carbon monoxide (CO) binding experiment was performed at room temperature. 
Fully oxidized purified protein (2.5µM), dissolved in 100mM Tris-HCl (pH 8.0) 
containing 100mM NaCl, was first reduced with dithionite and the spectrum was 
recorded (specR), followed by a short bubbling with carbon monoxide which spectra 
was also recorded (specR+CO). Carbon monoxide binding was analyzed based on 
specCO calculation which was calculated from (specR+CO minus specR) spectra. No 
spectral change is expected if no binding of CO is taking place. 
7. Differential scanning calorimetry 
The experiment was performed using N-DSCII machine. Purified protein 
(0.55mL of 15µM cyt bc1 complex) was first degassed at room temperature for 10 
min. Thermoscans from 10 to 90ºC at a rate of 1ºC/min and 2ºC/min were performed 
during the heating and cooling scans, respectively. Three scans were recorded, 
heating-cooling-heating, using the third scan as the baseline for the first scan. CpCalc 
program was used to calculate Tm values of purified proteins.  
 
8. Determination of redox potential of cyt c1 in wild type and mutant bc1
complex
The potentiometric titrations of cyt c1 were essentially done according to the 
previously published method (46, 47) using the following redox mediators (final 
concentration): diaminodurol (70µM), duroquinone (50µM), Pyocyanine (25µM), 
Anthroquinone-2-sulfonic acid (25µM), Indigo carmine (25µM), 1,2-naphthoquinone 
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(25µM), 1,4-benzoquinone (20µM) phenazine ethosulfate (20µM), phenazine 
methosulfate (20µM). Reductive potentiometric titrations were carried out using 
dithionite to reduce the ferricyanide oxidized sample and ferricyanide was used for 
oxidative titration of dithionite reduced sample. All titrations were performed at room 
temperature using a sealed anaerobic cuvette constantly flushed with argon. The 
midpoint potential of cyt c1 was calculated by fitting the redox titration data obtained 
to the Nernst equation for n = 1. 
9. Factor Xa proteolysis
The experiment was done based on a previously reported technique (37) with 
some minor modifications. The digestion was done using 150 nmoles of purified cyt 
bc1 complex in 50mM Tris-Cl, pH 8.0 containing 100mM NaCl and 0.01% SDS. The 
sample was incubated at 50ºC for 10 min. Factor Xa was then added, to a final 
concentration of 1% of total protein content, and the sample with the enzyme was 
incubated at room temperature for 16 hours. Afterwards, loading dye was added and 





RESULTS AND DISCUSSION 
 
A. Rhodobacter sphaeroides cytochrome c1 sensitivity to reducing agent in SDS 
gel electrophoresis 
 SDS gel electrophoresis of Rb. sphaeroides cyt c1 shows sensitivity to reducing 
agent, unlike the other three subunits cytochrome b, ISP and Subunit IX (30). Under 
reducing conditions, cyt c1 band shows as a sharp band whereas under non-reducing 
conditions it shows as a smear band. It was believed that sensitivity to reducing agent 
is associated with the presence of a disulfide bridge in the head domain of cyt c1
between the two non-heme binding cysteins (22, 48) but results presented herein 
show that in the absence of a potential disulfide bond, cyt c1 still shows as a smear 
band under non-reducing conditions. Both non-heme binding cysteins, C145 and 
C169 were mutated mutually to alanine and serine to prevent the formation of a 
disulfide bridge. Cytochrome bc1 complexes purified from mutants were run on SDS-
PAGE under reducing and non-reducing conditions. In each of the double mutants of 
cysteins to alanines (C145A/C169A) and cysteins to serines (C145S/C169S), cyt c1
shows as a sharp band under reducing conditions and as a smear band under non-
reducing conditions (Fig. 4). These results contradict the previously suggested 
hypothesis and confirm that the sensitivity of cyt c1 to reducing agent is not related to
- 23 -
Figure 4: SDS-PAGE analysis of the cyt bc1 complexes isolated from wild type and 
cystein mutants and of bovine heart mitochondrial cyt c1 and horse heart 
cyt c. Samples of protein (75pmoles) were incubated under reducing (+ β-
ME) or non-reducing conditions (- β-ME) at 60ºC for 5min. Cytochrome 
c1 band shows as a sharp band under reducing conditions and a smeared 
band under non-reducing conditions in each of samples.
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the presence of a disulfide bond. To examine whether such behavior is observed with 
Rb. sphaeroides cyt c1 only or with other c-type cytochromes as well, horse heart cyt 
c and bovine heart mitochondrial cyt c1 were run on SDS-page under reducing and 
non-reducing conditions (Fig. 4). Results show that both type c cytochromes are also 
sensitive to the presence of reducing agent. Both type c-cytochromes show as a sharp 
band and as a smear band in the presence and absence of β-mercaptoethanol, 
respectively. However, Rb. capsulatus cyt c1, which contains a disulfide bridge 
between the non-heme binding cysteins, shows no such sensitivity and appears as a 
sharp band under reducing and non-reducing conditions (37).  The reason for Rb. 
capsulatus cyt c1 not to show as a smear band under non-reducing conditions (37) is 
most likely due to the small amount of sample used, because when a small amount of 
horse cyt c and larger wells are used less smear band is observed. Although no 
explanation for the sensitivity of heme-containing protein to reducing agent can be 
drawn from these results, it is obvious that the sensitivity of cyt c1 to the presence or 
absence of reducing agent is not associated with the presence or absence of disulfide 
bond(s), since neither horse heart cyt c (49) nor bovine heart mitochondrial cyt c1 (22, 
50), have a disulfide bond. More experiments will be done to reveal the structural 
characteristic(s) that affect the mobility of c- type cytochrome polypeptides under 
non-reducing conditions.  
 
B. Analysis of cystein mutants in cytochrome c1
The non-heme binding cysteins residues in cyt c1, C145 and C169, were mutated 
to alanine individually to generate the mutants C145A and C169A and mutually to  
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Strain Ps. Growth Enzymatic activity Tm (ºC) 
Cyt c1
CO binding 
Wild Type +++ 2.5 45.2 - 
C145A ++ 2.0 42.4 - 
C169A ++ 2.0 42.2 - 
C145A/C169A ++ 2.0 41.9 - 
C145S + 1.5 41.1 - 
C169S + 1.5 41.4 - 
C145S/C169S + 1.5 41.8 - 
Table 2: Characteristics of wild type and mutants’ cytochrome c1 of the cytochrome 
bc1 complex. Enzyme activity (specific activity) is expressed as µmol cyt 
cred/min/nmoles cyt b. Ps. (++) and (+) refer to a photosynthetic growth rate 
delayed by 24hrs and 36hrs, respectively, as compared to wild type 
photosynthetic growth rate (+++).  Methods used to calculate enzymatic 
activity, Tm and CO binding are described in Materials and Methods 
section. The data presented are mean values from three experiments. 
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generate the double mutant C145A/C169A. Mutants’ characteristics, summarized in 
Table 2, reveal that mutating cystein to alanine does not severely affect the cyt bc1
activity.  About 80% of wild type activity is retained in each of the single mutants and 
the double mutant. Mutants can still grow photosynthetically but with a delay of 24 
hours. These results suggest that the cysteins might be connected through a disulfide 
bridge since mutating one or both cysteins disrupt the disulfide bridge and have the 
same effect on mutant growth and mutant bc1 complex activity. One way to examine 
the structural importance of potential free cysteins is to mutate each and both cysteins 
to serine and generate the single mutants C145S and C169S and the double mutant 
C145S/C169S. Serine mutants also grow photosynthetically but with a delay of 36 
hours as compared to wild type and only 60% of wild type activity is retained, which 
is lower than alanine mutants activity. These results also imply that the cysteins are 
linked with a disulfide bridge in native protein and disruption of the bridge and 
insertion of two hydroxyl groups results in additional defect which results in lower 
protein activity. All purified mutants’ complexes were subject to SDS-PAGE analysis 
and no difference was observed as compared to wild type; all mutants’ complexes 
contain all four subunits with comparable intensity with the heme group covalently 
bound to cyt c1, detected by TMBZ heme staining (Fig. 5).  
Differential scanning calorimetry was used to check the stability of the mutant 
proteins. The melting temperature (Tm) of mutants’ cytochrome bc1 complexes were 
found to be 2.8 to 4.1ºC lower than that of wild type bc1 complex (Table 2) which 
suggests that the disulfide bridge is required to maintain protein stability. Lower 
activity and stability of the bc1 complex might be associated with a change in the  
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(A)             (B) 
Figure 5: (A) SDS-PAGE and (B) TMBZ heme staining analysis of the cyt bc1
complexes isolated from wild type and cystein mutants. Samples of 
protein (70pmoles) were incubated in the presence of β-mercaptoethanol 
as reducing agent at room temperature for 15min. 
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heme environment of cyt c1 caused by the disruption of the disulfide bond. To 
examine if any of the heme ligands of cyt c1 was altered by eliminating the disulfide 
bridge, we tested the ability of the mutant proteins to bind carbon monoxide. The 
difference spectra of (dithionite reduced + CO) minus (dithionite reduced) of mutated 
bc1 complex were recorded and were found to be comparable to wild type profile 
(Fig. 6), which indicate that the ligands of heme c1 are not affected by the disruption 
of the disulfide bond. 
 Since Rb. sphaeroides and Rb. capsulatus cyt c1 are closely related and 
structurally comparable due to the high percentage of identity between the sequences, 
solving the structure of Rb. capsulatus cyt bc1 complex (38) and of cyt c1 head 
domain specifically (Fig. 7) allowed us to predict and visualize the possible structural 
alterations upon disrupting the disulfide bridge. We believe that disrupting the 
disulfide bridge, which holds the extra fragment loop 2 close to the upper loop, results 
in the release of the extra fragment loop 2, which fluctuation between the upper loop 
and the lower loop (extra fragment loop 1) affects cyt c1 functionality, showed by 
lower enzyme activity due to the slower electron transfer between cyt c1 and cyt c,
and lower cyt bc1 complex stability, showed by lower Tm values.
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Figure 6: Carbon monoxide optical difference spectra of the cyt bc1 complexes 
isolated from wild type and each of the single and double alanine and 
serine mutants. Carbon monoxide binding was analyzed based on the 




Figure 7: The structure of Rb. capsulatus cyt c1 as reported by Berry, E. et. al. (26) 
used as a model to predict the structural effect of cystein mutations in Rb. 
sphaeroides cyt c1. The disulfide bond between the two cysteins is labeled 
“disulfide”. The two long extra-fragment loops present in both Rb. 
capsulatus and Rhodobacter sphaeroides cyt c1 are labeled extra-fragment 
loop 1 and loop 2 in this figure. The upper loop contains the first cystein 
(C145 in Rb. sphaeroides and C144 in Rb. capsulatus). 
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C. Effect of cystein mutation on the midpoint potential of cytochrome c1
Mutating the cysteins significantly affects the redox potential of cyt c1 by 
lowering it from 230 mV in wild type to as low as 59mV and 48mV in each of the 
alanine and serine mutants, respectively (Fig. 8, Table 3).  
The decrease in midpoint potential explains why cyt c1 is not fully reducible by 
ascorbate in any of the cystein mutants (Table 3). Only around 40% and 25% of cyt c1
is reduced by ascorbate in the alanine and serine mutants, respectively. However, 
dithionite can reduce all cytochrome c1 found in solution similar to wild type and 
cytochrome b as well (Fig. 9).  
The structural analysis discussed above explains the drop in midpoint potential and 
therefore the change in ascorbate reducibility. In some proteins, the extra-fragment 
loop folds close to its native position in wild type protein resulting in a percentage of 
the population - 40% in alanine mutants and 25% in serine mutants (Fig. 9) - to be 
reducable by ascorbate. In other proteins, the extra-fragment loop is dislocated farther 
from its original position, especially upon insertion of a serine residue which causes 
increased repulsion, resulting in a decrease in cyt c1 midpoint potential below its 
ability to be reduced by ascorbate. Clearly, the drop in midpoint potential is not 
caused by the alteration of any of the heme ligands since none of the mutants binds 
carbon monoxide but is most likely caused by the structural modification caused by 
loosening the extra fragment loop affecting the structural integrity around the heme. 
The decrease in redox potential makes cyt c1 not fully reducible by ascorbate but fully 
reducable by dithionite, which midpoint potential is lower than the measured 
midpoint potential of cyt c1 mutants.  
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Figure 8: Potentiometric titration of cytochrome c1 in purified cytochrome bc1
complexes from Wild type, P151I/F154R and one of each of the cystein 
mutants to alanine and serine. Plots legend: [ ] Wild type (Em = 235mV), 
[ ] P151I/F154R (Em = 210mV), [ ] C145A (Em = 64mV) and [ ]
C145S (Em = 48mV). The Em values for C169A, C145A/C169A, C169S 
and C145S/C169S mutants are listed in Table 2. Oxidative and reductive 
titrations were performed as described in Materials and Methods. The data 
were fit to the Nernst equation for n=1. 
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Figure 9:  Optical spectral properties of Wild type (thick solid lines), single and 
double alanine mutants (thin solid lines) and serine mutants (dashed lines). 
Cytochrome c1 (553nm) and cytochrome b (560nm) concentrations are 
measured as described in Materials and Methods. Percentage values 
corresponding to each spectrum are listed in Table 3. 
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Strain Enzymatic Activity  
% cyt c1 reduced by 
Asc Em (mV) 
Wild Type 2.5 100 235 
C145A 2.0 40 64 
C169A 2.0 40 62 
C145A/C169A 2.0 40 59 
C145S 1.5 25 48 
C169S 1.5 25 49 
C145S/C169S 1.5 25 51 
Table 3: Redox properties of wild type and mutants of cytochrome c1 of the 
cytochrome bc1 complex. Enzyme activity (specific activity) is expressed 
as µmol cyt cred/min/nmoles cyt b. Midpoint potential (Em) was measured 
as described in Materials and Methods.  
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D. Factor Xa digestion of cytochrome c1
If the disulfide bond exists, cleaving cyt c1 protein (33KD) between the two 
cysteins will generate two polypeptides linked through the disulfide bond. Therefore, 
when the product is run on SDS-PAGE under non-reducing condition, the product 
will show a similar profile to the undigested protein (33KDa band). However, under 
reducing conditions where β-mercaptoethanol is used to reduce the disulfide bond, 
the two peptides will be separated on SDS-PAGE. This approach is valid only if the 
cleavage site is specific and unique in the protein. Because the amino acid sequence 
of cyt c1 does not contain a unique site between the two cysteins, the sequence was 
screened for the closest match compared to different cleavage enzyme consensus 
sequence. At position 151-154, a PDGF sequence was mutated to an IDGR sequence, 
by generating the mutations P151I and F154R simultaneously to match Factor Xa 
cleavage consensus sequence (IDGR) (Fig.10). P151I/F154R double mutant proteins 
were purified and characterized and results observed are summarized in Table 4. 
Mutant cells grow photosynthetically at a same rate than wild type and the specific 
activity of purified protein is also comparable to wild type. The midpoint potential of 
cyt c1 double mutant was measured and determined to be 210mV (Fig. 8, Table 4) 
compared to wild type cyt c1 midpoint potential of 235mV. Since the P151I/F154R 
mutant has similar features to wild type, it is believed to have similar structural 
folding and can be used to test the presence of disulfide bond in native proteins. 
Results shown in Fig. 11 reveal that the two fragments remain linked under non-
reducing conditions and separate into two fragments of 18KDa and 15KDa, which  
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Figure 10:  A simplified scheme representing Factor Xa digestion of cyt c1. The 
PDGF sequence between the two non heme binding cysteins, C145 and 
C169, in cytochrome c1 was mutated to IDGR, Factor Xa consensus 
sequence. When the protein is treated with Factor Xa, it is cut into two 

















Wild Type +++ 2.5 45.2 100 235 - 
P151I/F154R +++ 2.5 44.9 100 210 - 
Table 4: Characteristics of wild type and P151I/F154R mutant cytochrome c1 of the 
cytochrome bc1 complex. Ps. Growth (+++) represents wild type growth 
behavior. Enzyme activity (specific activity) is expressed as µmol cyt 
cred/min/nmoles cyt b. Em is the midpoint potential of cytochrome c1 and 
Tm is the melting temperature of the cytochrome bc1 complex, each 
measured as described in Materials and Methods section.  
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Figure 11: SDS-PAGE analysis and TMBZ heme staining of factor Xa cleavage of 
the cytochrome bc1 complex of wild type and P151I /F154R mutant.  (A) 
SDS-PAGE profile of undigested (- Factor Xa) and digested (+ Factor Xa) 
wild type and Factor Xa cleavable mutant (P151I/F154R) cytochrome bc1
complex in the presence (+ β-ME) and absence (- β-ME) of reducing 
agent. Because Factor Xa cleavage site is absent in wild type protein, cyt 
c1 remains intact when the protein is digested.  
 (B) Heme-containing fragments were stained with TMBZ to further 
confirm the identity of each fragment. Western Blot against His-tag was 




represents the N- terminal fragment containing the heme group (Fig 11. Panel B) and 
the C-terminal fragment, respectively. These results confirm that the two non-heme 
binding cysteins in Rb. sphaeroides cyt c1 form a disulfide bridge. 
 
E. Conclusion 
 The structure of Rb. sphaeroides cytochrome bc1 complex has not been solved 
yet. The lack of structural data limits proper visualization of the orientation of 
insertions in the bacterial system. Molecular and biochemical techniques used in this 
study, with some insight from the structure of Rhodobacter capsulatus cytochrome 
bc1 complex allowed identification of the orientation, the state and the function of the 
cysteins, C145 and C169, in Rhodobacter sphaeroides cytochrome c1. The two 
cysteins where found to be connected through a disulfide bridge which holds the 
extra-fragment loop 2, containing C169, in a fixed position close to the upper loop, 
containing C145. Ile183 of the βXM motif does not seem to be correlated to the 
presence of the disulfide bridge since no revertants were observed.  
Disruption of the disulfide bridge seems to result in the release of the second extra 
fragment loop, which fluctuation slows the cytochrome bc1 complex activity and 
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